A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.
by Pamela Rafalow Grossman
People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.
by Jon Kelvey
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
From the Editor-in-Chief
Research is leading to treatments that target cancer’s support system.
by William G. Nelson, MD, PhD
Forward Look
Cellular immunotherapies can offer periods when people do not require treatment.
by Christina Bennett
Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.
by Kris Conner
Over a decade after human papillomavirus vaccines first became available in the U.S., their effect on cervical cancer incidence is becoming apparent.
by Carisa D. Brewster
Using fecal transplants to improve immunotherapy response
by Natalie Slivinski
Tumor testing can help determine whether certain cancers are likely to respond to immunotherapy drugs.
by Kendall K. Morgan
A study on aging shows that cancer survivors are at higher risk of losing strength and walking more slowly compared to those with no cancer history. Exercise is one way to combat this decline.
Insurance coverage for fertility treatments is not mandated by federal law, although some states require it. People seeking cancer treatment need to understand their coverage and the law in their state.
by Shelly Rosenfeld
Sooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
Olufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Federal funding could help cancer centers rebuild from the devastating effects of the pandemic.
Learning Medicare’s ABCDs
donate to the AACR